Vultaggio Vincent sold ZNTL
February 3, 2026 · Form 4 insider transaction
Vultaggio Vincent sold 556 shares of Zentalis Pharmaceuticals, Inc. at $2.52 per share, a transaction worth $1.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
556
Price
$2.52
Total value
$1.4K
InsiderVultaggio Vincent
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 3, 2026
Filing dateFebruary 4, 2026
Shares owned after186,730
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This sale was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person.